Status | Study |
Withdrawn |
Study Name: Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye Condition: Ocular Melanoma Date: 2008-02-11 Interventions: Drug: Pegylated Interfon Alpha 2B |
Terminated |
Study Name: Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma Condition: Intraocular Melanoma Date: 2007-06-20 Interventions: Drug: cisplatin Drug: sunitinib malate |
Terminated |
Study Name: Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma Condition: Intraocular Melanoma Malignant Conjunctival Neoplasm Date: 2007-06-04 Interventions: Drug: cyclophosphamide 25-50 m |
Completed |
Study Name: Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye Condition: Extraocular Extension Melanoma Recurrent Intraocular Melanoma Date: 2007-03-02 Interventions: Drug: gp100 antigen Drug: interleukin-2 |
Terminated |
Study Name: Imatinib in Adult Patients With Metastatic Ocular Melanoma Condition: Melanoma Date: 2007-01-09 Interventions: Drug: Imatinib 800 mg/day until disease progression or toxicity |
Completed |
Study Name: Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone Condition: Ocular Melanoma Choroidal Melanoma Date: 2006-07-12 |
Recruiting |
Study Name: Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy Condition: Ocular Melanoma Date: 2006-06-27 |
Recruiting |
Study Name: Cytogenetic Study of Ocular Melanoma Condition: Choroidal Melanoma Date: 2006-06-26 |
Completed |
Study Name: Study of Metastatic Ocular Melanoma Condition: Ocular Melanoma Date: 2005-09-09 Interventions: Drug: Gemcitabine Drug: Treosulfan |
Completed |
Study Name: Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma Condition: Melanoma Date: 2005-04-21 Interventions: Drug: Revlimid oral dose (1 capsule) 25 mg per day 7 days a week for cohort 1 oral dose (1 capsule) 5 mg |